CSIMarket
 


Champions Oncology Inc   (CSBR)
Other Ticker:  
 


Champions Oncology Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CSBR Gross Profit Margin (Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
(Jan 31 2023)
III. Quarter
Y / Y Revenue Change -5.9 % -18.96 % -8.61 % 1.51 % -3.18 %
Seq. Revenue Change 3.85 % -7.87 % -3.9 % 2.33 % -10.56 %
Revenue In Millions $12.02 $11.57 $12.56 $13.07 $12.77
Gross Profit Margin 34.7 % 42.82 % 38.83 % 43.86 % 39.72 %
Gross Profit Margin Total Ranking # 2045 # 2703 # 2992 # 2803 # 3306
Gross Profit In Millions $4.17 $4.96 $4.88 $5.73 $5.07
Y / Y Gross Profit Change -17.82 % -27.54 % -27.13 % -13.87 % -25.24 %
Seq. Gross Profit Change -15.84 % 1.6 % -14.93 % 12.99 % -25.8 %


Commenting Third Quarter 2023 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 34.7 % due to increase in Cost of Sales and despite Revenue increase of 3.85 % to $12 millions.
Champions Oncology Inc achieved highest Gross Profit Margin in III. Quarter

Observing third quarter 2023 results within Biotechnology & Pharmaceuticals industry 46 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2045, from total ranking in previous quarter at 2703.
Learn about Gross Margin
CSBR's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 334
Overall # 2043

Gross Profit Margin Statistics
High Average Low
236.68 % 82.32 % 34.7 %
(Apr 30 2020)   (Jan 31 2024)




Other Gross Profit Margin Profitability Ratios
CSBR's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CSBR's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CSBR's Competitors
Gross Profit Margin Profit Margin for Champions Oncology Inc 's Suppliers
Gross Profit Margin Profit Margin for CSBR's Customers

You may also want to know
CSBR's Annual Growth Rates CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Gross Profit Growth
CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jan 31 2024, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginJan 31 2024 MRQ Gross ProfitJan 31 2024 MRQ Revenue
Argenx se  95.28 %$ 2,377.075 $ 2,494.910 
Vir Biotechnology Inc   95.25 %$ 15.989 $ 16.787 
Springworks Therapeutics Inc   92.25 %$ 5.025 $ 5.447 
Tarsus Pharmaceuticals Inc   90.70 %$ 11.860 $ 13.076 
Zeo Scientifix Inc   86.22 %$ 0.995 $ 1.154 
Biontech Se  84.29 %$ 3,605.504 $ 4,277.280 
Halozyme Therapeutics Inc   77.27 %$ 177.741 $ 230.039 
Vericel Corporation  74.63 %$ 48.507 $ 64.996 
Biogen Inc   74.09 %$ 1,768.000 $ 2,386.300 
Cyclo Therapeutics Inc   72.91 %$ 0.227 $ 0.311 
Gilead Sciences Inc   70.62 %$ 5,024.000 $ 7,114.000 
Sophia Genetics Sa  69.31 %$ 42.913 $ 61.913 
Moderna Inc   66.95 %$ 1,882.000 $ 2,811.000 
Qiagen N v   64.91 %$ 1,233.688 $ 1,900.688 
Bio techne Corp  64.78 %$ 176.587 $ 272.587 
Amgen Inc   62.03 %$ 5,084.000 $ 8,196.000 
Creative Medical Technology Holdings Inc   60.00 %$ 0.002 $ 0.003 
Novavax inc  46.81 %$ 136.366 $ 291.342 
Adma Biologics Inc   41.62 %$ 31.086 $ 74.686 
Twist Bioscience Corporation  40.51 %$ 28.962 $ 71.498 
Zivo Bioscience Inc   35.01 %$ 0.004 $ 0.012 
Champions Oncology Inc   34.70 %$ 4.170 $ 12.019 
Valneva Se  34.37 %$ 59.179 $ 172.159 
Protalix Biotherapeutics inc   15.54 %$ 1.630 $ 10.486 
Elutia inc   13.80 %$ 0.901 $ 6.530 
Recursion Pharmaceuticals Inc   9.28 %$ 1.011 $ 10.891 
Coherus Biosciences inc   7.60 %$ 6.957 $ 91.524 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com